Development and Evaluation of DNA Vaccine Against Salmonid Alphavirus.

Methods Mol Biol

Laboratory of Fish Immunology, Institute of Infectology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.

Published: January 2022

Despite vaccination, pancreas disease (PD) caused by salmonid alphavirus (SAV) has been the economically most important virus disease in salmon farming in Ireland, Scotland, and Norway. A vaccine based on DNA plasmid has been authorized to be used in Norwegian aquaculture since 2018. DNA vaccination of plasmids expressed subcellular viral proteins have been shown its particular protective effect against SAV3 that surface expression of the E2 protein with the whole viral protein construct, yielding a more effective vaccine. The chapter describes methods to design and test the sublocalization of expressed viral protein and the performance evaluation of vaccines against SAV3 infection in Atlantic salmon.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-1888-2_12DOI Listing

Publication Analysis

Top Keywords

salmonid alphavirus
8
viral protein
8
development evaluation
4
evaluation dna
4
dna vaccine
4
vaccine salmonid
4
alphavirus despite
4
despite vaccination
4
vaccination pancreas
4
pancreas disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!